These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35098746)

  • 61. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
    Lester CA; Mott DA; Chui MA
    J Manag Care Spec Pharm; 2016 Jul; 22(7):801-7. PubMed ID: 27348281
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage.
    Wu VC; Huang YC; Chen SW; Liu CH; Chang CW; Chen CC; Chang SH; Lin MS; Lee TH; Chen MC; Hsieh IC; Chu PH; Lin YS
    Medicine (Baltimore); 2021 Aug; 100(32):e26945. PubMed ID: 34397946
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
    Banerjee A; Benedetto V; Gichuru P; Burnell J; Antoniou S; Schilling RJ; Strain WD; Ryan R; Watkins C; Marshall T; Sutton CJ
    Heart; 2020 Jan; 106(2):119-126. PubMed ID: 31601729
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
    Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
    Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Guideline-concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part D.
    Done N; Roy AM; Yuan Y; Pizer SD; Rose AJ; Prentice JC
    Health Serv Res; 2019 Feb; 54(1):128-138. PubMed ID: 30417341
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Physician Perception of Patient Medication Adherence in a Cohort of Medicare Advantage Plans in Texas.
    Winters A; Esse T; Bhansali A; Serna O; Mhatre S; Sansgiry S
    J Manag Care Spec Pharm; 2016 Mar; 22(3):305-12. PubMed ID: 27003560
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends in Drug Spending of Oral Anticoagulants for Atrial Fibrillation, 2014-2021.
    Lee JS; Han S; Therrien NL; Park C; Luo F; Essien UR
    Am J Prev Med; 2024 Mar; 66(3):463-472. PubMed ID: 37866490
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable.
    Piccini JP; Xu H; Cox M; Matsouaka RA; Fonarow GC; Butler J; Curtis AB; Desai N; Fang M; McCabe PJ; Page Ii RL; Turakhia M; Russo AM; Knight BP; Sidhu M; Hurwitz JL; Ellenbogen KA; Lewis WR;
    Circulation; 2019 Mar; 139(12):1497-1506. PubMed ID: 30700141
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.
    Deguchi I; Osada T; Arai N; Takahashi S
    Heart Vessels; 2022 May; 37(5):867-874. PubMed ID: 34797401
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
    Kale HP; Patel AM; Carroll NV
    J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development and validation of a drug adherence index for COPD.
    Bengtson LGS; Bancroft T; Schilling C; Buikema AR; Stanford RH
    J Manag Care Spec Pharm; 2021 Feb; 27(2):198-209. PubMed ID: 33506734
    [No Abstract]   [Full Text] [Related]  

  • 73. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry.
    Hsu JC; Maddox TM; Kennedy KF; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM
    JAMA Cardiol; 2016 Apr; 1(1):55-62. PubMed ID: 27437655
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Increases in Medicare prescription drug plan costs attributable to psychotropic medications.
    Zivin K; McCammon RJ; Davis MM; Halasyamani LK; Kales HC
    Am J Geriatr Psychiatry; 2008 Aug; 16(8):674-85. PubMed ID: 18669946
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Formulary restrictions and stroke risk in patients with atrial fibrillation.
    Zhou B; Seabury S; Goldman D; Joyce G
    Am J Manag Care; 2022 Oct; 28(10):521-528. PubMed ID: 36252171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost minimization of medicare part D prescription drug plan expenditures.
    Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
    Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
    [TBL] [Abstract][Full Text] [Related]  

  • 78. COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data.
    Hernandez I; Gabriel N; He M; Guo J; Tadrous M; Suda KJ; Magnani JW
    J Am Heart Assoc; 2021 Dec; 10(24):e023235. PubMed ID: 34913359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    Hsu JC; Maddox TM; Kennedy K; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM
    J Am Coll Cardiol; 2016 Jun; 67(25):2913-23. PubMed ID: 27339487
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
    Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
    Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.